(Alliance News) - Neosperience Spa announced Friday that the extraordinary shareholders' meeting of Neosperience Health Spa, a 90 percent subsidiary of NSP, yesterday approved a capital increase aimed at listing on the U.S. capital market.

The capital increase provides for the issuance of up to 100.0 million shares to serve the placement on the U.S. markets and further future capital raisings in Italy or abroad. Upon completion of the IPO, expected indicatively by the end of 2023, NSP will still maintain a controlling stake in NH.

The meeting also approved new bylaws, the effectiveness of which is subject to the start of trading on the U.S. market.

Neosperience Health, incorporated in May 2022, inherited the activities carried out in the past years by NSP in the health sector and has recently developed a software platform, Neosperience Health Cloud, aimed at outpatient clinics, diagnostic centers, and public and private hospitals, which enables the digitization of diagnosis, prevention, and patient care processes through the use of sophisticated artificial intelligence algorithms.

"With the proceeds from the listing on the U.S. market, NH intends to accelerate its growth, in Italy and in the main European countries, with the aim of subsequently developing its activities in the U.S. as well," the Neosperience note reads.

Neosperience's stock is up 14 percent to EUR2.03 per share.

By Giuseppe Fabio Ciccomascolo, Alliance News senior reporter

Comments and questions to redazione@alliancenews.com

Copyright 2023 Alliance News IS Italian Service Ltd. All rights reserved.